Riskpilot← Back to searchSign inGet full accessKAPPA SOLUTIONS AS
ASActiveOrg 882512142Silurveien 2B, 4. Etasje, 0380 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20008 employees
Revenue 2025
NOK 17,2M
-24% vs 2024
EBITDA margin
-0.3%
-106% vs 2024
Equity ratio
83.5%
Financial strength
Net profit 2025
NOK 104K
-87% vs 2024
| Revenue | NOK 17,2M | -24% |
| EBITDA | NOK -57K | -106% |
| Net profit | NOK 104K | -87% |
| Total assets | NOK 20,8M | -1% |
| Equity | NOK 17,4M | +1% |
| Employees | 8 | — |
Legal name
KAPPA SOLUTIONS AS
Org number
882512142
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. oktober 2000
Share capital
NOK 200 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Syntese av kjemiske produkter.
Address
Silurveien 2B, 4. Etasje, 0380 Oslo
Phone
+4799699120
Email
info@synthetica.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11 712 | 7 229 | 9 472 | 10 318 | 14 058 | 13 962 | 14 709 | 11 822 | 10 064 | 24 662 | 16 795 | 13 287 | 13 638 | 20 129 | 21 700 | 21 915 | 22 681 | 17 193 |
| Staff expenses | −4 362 | −3 926 | −3 791 | −4 209 | −4 859 | −5 028 | −5 464 | −5 078 | −5 086 | −5 015 | −6 159 | −5 265 | −6 822 | −8 111 | −9 361 | −10 333 | −0 | −0 |
| EBITDA | 3 481 | 590 | 2 195 | 2 380 | 5 665 | 4 512 | 5 277 | 2 907 | 1 231 | −1 068 | 193 | 1 793 | 2 398 | 7 250 | 5 645 | 3 962 | 938 | −57 |
| Depreciation & amort. | −26 | −31 | −59 | −113 | −210 | −261 | −219 | −238 | −247 | −195 | −41 | −63 | −117 | −237 | −293 | −267 | −268 | −198 |
| EBIT | 3 455 | 560 | 2 136 | 2 267 | 5 456 | 4 251 | 5 058 | 2 669 | 983 | −1 263 | 152 | 1 731 | 2 281 | 7 013 | 5 352 | 3 695 | 670 | −255 |
| Net financials | 99 | 26 | 37 | 1 519 | 25 | 72 | 3 576 | 151 | 12 | −214 | −20 | −25 | −39 | −13 | 139 | 409 | 357 | 403 |
| Profit before tax | 3 554 | 586 | 2 173 | 3 786 | 5 481 | 4 323 | 8 634 | 2 820 | 995 | −1 477 | 132 | 1 705 | 2 242 | 6 999 | 5 491 | 4 103 | 1 027 | 148 |
| Tax | 846 | 61 | 504 | 509 | 1 424 | 1 092 | 1 242 | 649 | 181 | −335 | 48 | 375 | 493 | 1 540 | 1 209 | 903 | −0 | −0 |
| Net profit | 2 708 | 525 | 1 668 | 3 277 | 4 056 | 3 230 | 7 392 | 2 171 | 814 | −1 143 | 84 | 1 330 | 1 748 | 5 460 | 4 283 | 3 201 | 801 | 104 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 497 | 6 245 | 7 754 | 9 052 | 11 451 | 11 643 | 19 229 | 8 562 | 4 651 | 6 939 | 5 112 | 7 262 | 9 289 | 13 368 | 18 650 | 21 590 | 21 011 | 20 787 |
| Equity | 3 874 | 4 399 | 6 068 | 3 744 | 4 801 | 8 031 | 9 423 | 1 294 | 1 498 | 356 | 439 | 1 769 | 3 518 | 8 977 | 13 260 | 16 461 | 17 262 | 17 366 |
| Long-term debt | 50 | 0 | 0 | 0 | 21 | 14 | 7 | 0 | 0 | 812 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 573 | 1 803 | 1 651 | 5 279 | 6 629 | 3 598 | 9 799 | 7 268 | 3 152 | 5 771 | 4 673 | 5 492 | 5 771 | 4 391 | 5 390 | 5 129 | 3 750 | 3 421 |
| Total debt | 1 623 | 1 846 | 1 686 | 5 308 | 6 650 | 3 612 | 9 806 | 7 268 | 3 152 | 6 584 | 4 673 | 5 492 | 5 771 | 4 391 | 5 390 | 5 129 | 3 750 | 3 421 |
EBITDA margin
-0.3%
This company
15.8%
Market median
-102% vs market
20082025
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
20082025
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
20082025
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20082025
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20082025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IR Chief Executive Officer | Chief Executive Officer | 2000 | — | — |
KS Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kappa Bioscience As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kechu Bidco As
KAPPA SOLUTIONS AS Board members of KAPPA SOLUTIONS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Reidun Fjeldskaar Aukrust | Chief Executive Officer | 0 companies |
| Kai Schröder | Chief Executive Officer | 0 companies |
| Theodore Lee Harris | Chairman | 0 companies |
| Job Leonard Anthonie Van Gunsteren | Board of Directors | 0 companies |
| Egil Greve | Chairman | 0 companies |